Ensysce Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Ensysce Biosciences

16/08/2024 22:01

* Ensysce Biosciences Inc  ENSC.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -98 cents.  The mean expectation of two analysts
for the quarter was for a loss of 39 cents per share. Wall
Street expected results to range from -45 cents to -33 cents per
share.
    * Revenue fell 62.9% to $181.80 thousand from a year ago;
analysts
expected $300.00 thousand. 
    * Ensysce Biosciences Inc's reported EPS for the quarter was
a
loss of 22 cents​.
    * The company reported a quarterly loss of $1.97 million.
    * Ensysce Biosciences Inc shares had fallen by 22.4% this
quarter and lost 62.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 14.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * 
    * Wall Street's median 12-month price target for Ensysce
Biosciences Inc is $12.63 

This summary was machine generated from LSEG data August 16 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.39          -0.22          Beat
 Mar. 31 2024      -0.90          -0.55          Beat
 Dec. 31 2023      -0.87          -1.37          Missed
 Sep. 30 2023      -1.06          -0.87          Beat